PUMA BIOTECHNOLOGY, INC. |
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 4.385 USD | +5.16% |
|
-5.59% | +1.39% |
| 17/05 | Pfizer wins $107.5 million from AstraZeneca in US cancer drug patent trial | RE |
| 02/05 | Transcript : Puma Biotechnology, Inc., Q1 2024 Earnings Call, May 02, 2024 |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Sector Other Biotechnology & Medical Research
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
|---|---|---|---|---|---|---|
| 20Cr | - | - | ||||
| 5.51TCr | - | |||||
| 4.18TCr | ||||||
| 4.02TCr | ||||||
| 2.82TCr | ||||||
| 2.63TCr |
